Accelerated osteoporosis in psychiatric patients: Possible pathophysiological processes

Schizophrenia Bulletin

Volumn 22, Issue 3, 1996, Pages 447-454

  Halbreich, Uriel ^a,b   Palter, Steven ^a,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; BONE DENSITY; BONE MINERAL; CALCIUM INTAKE; DEPRESSION; FRACTURE; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SMOKING;

EID: 0029833245     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/22.3.447     Document Type: Review

References (60)

1. Abraham, G.; Friedman, R.H.; Verghese, C.; and de Leon, J. Osteoporosis and schizophrenia: Can we limit known risk factors? [Letter] Biological Psychiatry, 38:131, 1995.
2. Apter, A.; Dickerman, Z.; Gonen, N.; Asa, S.; Prager-Lewin, R.; Kaufman, H.; Tyano, S.; and Laron, Z. Effect of chlorpromazine on hypothalamic-pituitary-gonadal function in 10 adolescent schizophrenic boys. American Journal of Psychiatry, 140:1588-1591, 1983.
3. Ataya, K.; Mercada, A.; Kartaginer, J.; Abbasi, A.; and Moghissi, K.S. Bone density and reproductive hormones in patients with neuroleptic induced hyperprolactinemia. Fertility and Sterility, 50:876-880, 1988.
4. Baldessarini, R.J. Drugs in the treatment of psychiatric disorders. In: Goodman, L., and Gilman, A., eds. The Pharmacological Basis of Therapeutics. 7th ed. New York, NY: Macmillan Press, 1993. pp. 387-445.
5. Beaumont, P.J.V.; Corker, C.S.; and Sriesen, H.G. The effects of phenothiazines on endocrine function: II. Effects in men and postmenopausal women. British Journal of Psychiatry, 124:420-430, 1974.
6. Bertolini, D.R.; Nedwin, G.E.; Bringman, T.S.; Smith, D.D.; and Myndy, G.R. Stimulation of bone resorption inhibition of bone formation in vitro by human tumor necrosis factors. Nature, 319:516-518, 1986.
7. Billier, B.M.; Saxe, V.; Herzog, D.B.; Rosenthal, D.I.; Holzman, S.; and Klibanski, A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 68:548-554, 1989.
8. Brown, W.A.; Laughren, T.P.; and Williams, B. Differential effects of neuroleptic agents on the pituitarygonadal axis in men. Archives of General Psychology, 38:1270-1272, 1981.
9. Consensus Conference. Osteoporosis. Journal of the American Medical Association, 252:799-802, 1984.
10. Cummings, S.R.; Kelsey, J.L.; Nevitt, M.C.; and O'Dowd, K.G. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiologic Reviews, 7:178-208, 1985.
11. Cummings, S.R.; Rubin, S.M.; and Black, D. The future of hip fractures in the United States: Numbers, costs, and potential effects of postmenopausal estrogen. Clinical Orthopaedics and Related Research, 252:163-166, 1990.
12. de Leon, J.; Dadvand, M.; Canuso, C.; White, A.O.; Stanilla, J.K.; and Simpson, G.M. Schizophrenia and smoking: An epidemiological survey in a State hospital. American Journal of Psychiatry, 152(3):453-455, 1995.
13. de Leon, J.; Verghese, C.; Tracy, J.; Josiassen, R.; and Simpson, G.M. Polydipsia and water intoxication in psychiatric patients: A review of the epidemiological literature. Biological Psychiatry, 35:408-419, 1994.
14. Delva, N.J.; Crammer, J.L.; Jarzylo, S.V.; Lawson, J.S.; Owan, J.A.; Sribney, M.; Weir, B.J.; and Yendt, E.R. Osteopenia, pathological fractures, and increased calcium excretion in schizophrenic patients with polydipsia. Biological Psychiatry, 26:781-793, 1989.
15. Denicoff, K.D.; Rubinow, D.R.; Papa, M.Z.; Simpson, C.; Seipp, C.A.; Lotze, M.T.; Chang, A.E.; Rosenstein, D.; and Rosenbert, S.A. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Annals of Internal Medicine, 107:293, 1987.
16. Fallon, M.D.; Perry, H.M.; and Bergfeld, G. Exogenous hyperthyroidism with osteoporosis. Archives of Internal Medicine, 143:442-444, 1983.
17. Foresta, C.; Scanelli, G.; Sanatta, G.P.; Busnardo, B.; and Scandellari, C. Reduced calcitonin reserve in young hypogonadic osteoporotic men. Hormone and Metabolic Research, 19:275-277, 1987.
18. Foresta, C.; Zanatta, G.P.; Busnardo, B.; Scanelli, G.; and Scandellari, C. Testosterone and calcitonin plasma levels in hypogonadal osteoporotic young men. Journal of Endrocrinological Investigation, 8:377-379, 1985.
19. Francis, R.M.; Peacock, M.; Aaron, H.J.E.; Selby, P.L.; Taylor, G.A.; Thompson, J.; Marshall, D.H.; and Horsman, A. Osteoporosis in hypogonadal men: Role of decreased plasma, 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone, 7:261-268, 1986.
20. Gown, M.; Nedwin, G.E.; and Mundy, G.R. Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. Journal of Bone and Mineral Research, 1:469-174, 1986.
21. Greenspan, S.L.; Neer, R.M.; Ridgway, E.C.; and Klibanski, A. Osteoporosis in men with hyperprolactinemic hypogonadism. Annals of Internal Medicine, 104:777-782, 1986.
22. Hahn, T.J. Drug induced disorders of vitamin D and mineral metabolism. Journal of Clinical Endocrinology and Metabolism, 9:107, 1980.
23. Halbreich, U.; Rojansky, N.; Palter, S.; Hreshchyshyn, M.; Kreeger, J.; Bakhai, Y.; and Rosan, R. Decreased bone mineral density in medicated psychiatric patients. Psychosomatic Medicine, 57:485-491, 1995.
24. Hattner, R.; Epker, B.N.; and Frost, H.M. Suggested sequential mode of control of changes in cell behaviour in adult bone remodeling. Nature, 206:489, 1965.
25. Hui, S.L.; Selmenda, C.W.; and Johnston, C.C., Jr. Age and bone mass as predictors of fracture in a prospective study. Journal of Clinical Investigation, 81:1804-1809, 1988.
26. Jensvold, M.A.; Halbreich, U.; and Hamilton, J.A., eds. Psychopharmacology of Women: Sex, Gender, and Hormonal Considerations. Washington, DC: American Psychiatric Press, 1966.
27. Kartaginer, J.; Ataya, K.; Mercado, A.; and Abbasi, A. Osteoporosis associated with neuroleptic treatment: A case report. Journal of Reproductive Medicine, 35:198-202, 1990.
28. Klibanski, A.; Neer, R.; Beitins, I.Z.; Ridgway, E.C.; Zerva, N.T.; and McArthur, J. Decreased bone density in hyperprolactinemic women. New England Journal of Medicine, 303:1155-1514, 1981.
29. 3H] tetracycline excretion from prelabeled mice. Journal of Bone and Mineral Research, 3:621-627, 1988.
30. Kutsuma, K. Bone histomorphometric study of the ilium in psychiatric patients with long term administration of anti-psychiatric drug. Journal of the Japanese Orthopaedic Association, 67:583-590, 1993.
31. Lacro, J.P., and Jeste, D.V. Physical comorbidity and polypharmacy in older psychiatric patients. Biological Psychiatry, 36:146-152, 1994.
32. Laughren, T.P.; Brown, W.A.; and Petrucci, J.A. Effects of thioridazine on serum testosterone. American Journal of Psychiatry, 135:982-984, 1978.
33. Levinson, D.F., and Simpson, G.M. Antipsychotic drug side effects. In: Hales, R.E., and Frances, A.J., eds., Psychiatry Update: American Psychiatric Association Annual Review. Vol. 6. Washington, DC: American Psychiatric Press, 1987. pp. 704-723.
34. Lindholm, J.; Steiniche, T.; Rasmussen, E.; Thamsborg, G.; Nielsen, I.O.; and Brockstedt-Rasmussen, H. Bone disorder in men with chronic alcoholism: A reversible disease? Journal of Clinical Endocrinology and Metabolism, 73:118-124, 1991.
35. Lindsay, R.; Aitkin, J.M.; Anderson, J.B.; Hart, D.M.; MacDonald, E.B.; and Clark, A.C. Long-term prevention of post menopausal osteoporosis by oestrogen. Lancet, 1:1038, 1976.
36. Mundy, R.T. Cytokines and growth factors in regulation of bone remodeling. Journal of Bone and Mineral Research, 8(Suppl. 2):505, 1993.
37. Musso, T.; Espinoza-Delgado, I.; Pulkki, K.; Guselle, G.L.; Longo, D.L.; and Varesio, L. IL-2 induces IL-6 production in human monocytes. Journal of Immunology, 148:795-800, 1992.
38. Newman, M.M., and Halmi, K.A. Relationship of bone density to estradiol and cortisol in anorexia nervosa and bulimia. Psychiatry Research, 29:105-112, 1989.
39. Okonmah, A.D.; Bradshaw, W.G.; Couceyro, P.; and Soliman, K.F. The effect of neuroleptic drugs on serum testosterone levels in the male rat. General Pharmacology, 17:235-238, 1986.
40. Rapaport, M.H.; McAllister, C.C.; Pickar, D.; Nelson, D.L.; and Paul, S.M. Elevated levels of soluble interleukin-1 receptors in schizophrenia. Archives of General Psychiatry, 46:291-292, 1989.
41. Regier, D.A.; Boyd, J.H.; Burke, J.D.; Rae, D.S.; Myers, J.K.; Kramer, M.; Robins, L.N.; George, L.K.; Karno, M.; and Locke, B.Z. One-month prevalence of mental disorders in the United States: Based on five epidemiologic catchment area sites. Archives of General Psychiatry, 45(11):977-986, 1988.
42. Riggs, B.L. Osteoporosis - A disease of impaired homeostatic regulation. [Editorial] Mineral and Electrolyte Metabolism, 5:265-272, 1981.
43. Rigotti, N.A.; Neer, R.M.; and Jameson, L. Osteopenia and bone fractures in a man with anorexia nervosa and hypogonadism. Journal of the American Medical Association, 256:385-388, 1986.
44. Rinieris, P.; Hatzimanolis, J.; Markianon, M.; and Stefanis, C. Effects of treatment with various doses of haloperidol on the pituitarygonadal axis in male schizophrenic patents. Neuropsychobiology, 22:146-149, 1989.
45. Rojansky, N.; Halbreich, U.; Rosan, R.; Wang, K.; and Hreshchyshyn, M. Hormonally related osteoporosis in chronic psychiatric patients. [Abstract] Neuroendocrinology Letters, 12:304, 1990.
46. Rubin, R.T. Plasma prolactin and testosterone during penfluridol treatment. [Letter] Lancet, II(8190):370, 1980.
47. Salisbury, J.J., and Mitchell, J.E. Bone mineral density and anorexia in women. American Journal of Psychiatry, 148:768-774, 1991.
48. Sandison, R.A.; Whitelaw, E.; and Currie, J.D. Clinical trials with melleril [sic] (TP21) in the treatment of schizophrenia: A two-year study. Journal of Mental Science, 106:732-741, 1960.
49. Schlechter, J.A.; Sherman, B.; and Martin, R. Bone density in amenorrheic women with and without hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 56:1120-1123, 1983.
50. Schweiger, U.; Deuschle, M.; Korner, A.; Schmider, J.; Gotthardt, U.; Backmund, H.; Rothetmund, J.; Holsboer, F.; and Heuser, I. Bone mineral density in patients with major depression. [Abstract] Biological Psychiatry, 33:76, 1993.
51. Seibyl, J.P.; Altemus, M.; Charney, D.S.; Krystal, J.H.; and Licinio, J. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. American Journal of Psychiatry, 150:1408-1410, 1993.
52. Seman, E.; Melton, L.J. III; O'Fallon, W.M.; and Riggs, B.L. Risk factors for spinal osteoporosis in men. American Journal of Medicine, 75:977-983, 1983.
53. Siris, S.G.; Siris, E.S.; van Kammen, D.P.; Docherty, J.P.; Alexander, P.E.; and Bunney, W.E., Jr. Effects of dopamine blockade on gonadotropins and testosterone in men. American Journal of Psychiatry, 137:211-214, 1980.
54. Smith, R.S. Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? Medical Hypotheses, 34:225-229, 1991.
55. Stanley, H.L.; Schmitt, B.P.; Poses, R.M.; and Deiss, W.P. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? Journal of the American Geriatrics Society, 39:766-771, 1991.
56. Steele, F.R. Evolutions: Bone remodeling. Journal of NIH Research, 7:78-87, 1995.
57. Thys-Jacobs, S.; Silverton, M.; and Alvir, J. "Vitamin D and Calcium Inadequacy in Women With Premenstrual Syndrome: Evidence of Reduced Bone Mass." [Abstract 1034c] Presented at 75th Annual Meeting of the Endocrine Society, Las Vegas, NV, June 9-12, 1993.
58. Urry, R.L.; Dougherty, K.A.; and Cockett, A.T. Age-related changes in male rat reproductive organ weights and plasma testosterone concentrations after administration of a monoamine oxidase inhibitor. Fertility and Sterility, 27:1326-1334, 1976.
59. Vignery, A.; Niven-Fairchild, T.; and Chepard, M. Recombinant murine interferon-γ inhibits the fusion of mouse alveolar macrophages in vitro but stimulates the formation of osteoclast-like cells on implanted syngeneic bone particles in vivo. Journal of Bone and Mineral Research, 5(6):637-644, 1990.
60. Zylstra, S.; Hopkins, A.; Erk, M.; and Hreshchyshyn, M. Effect of physical activity on lumbar spine and femoral neck bone densities. International Journal of Sports Medicine, 3:181-186, 1989.